Palmitoylome profiling indicates that androgens regulate the palmitoylation of α‑tubulin in prostate cancer‑derived LNCaP cells and supernatants

Li,Wenqing; Zhang,Junhua; Zou,Lihui; Cui,Jian; Su,Fei; Jin,Junhua; Xiao,Fei; Liu,Ming; Zhao,Gang

doi:10.3892/or.2019.7333

Palmitoylome profiling indicates that androgens regulate the palmitoylation of α‑tubulin in prostate cancer‑derived LNCaP cells and supernatants

Authors:
- Wenqing Li
- Junhua Zhang
- Lihui Zou
- Jian Cui
- Fei Su
- Junhua Jin
- Fei Xiao
- Ming Liu
- Gang Zhao
View Affiliations

Affiliations: The MOH Key Laboratory of Geriatrics, Beijing Hospital, National Center of Gerontology, Beijing Hospital, Beijing 100730, P.R. China, Department of General Surgery, Beijing Hospital, Beijing 100730, P.R. China, Department of Pathology, Beijing Hospital, Beijing 100730, P.R. China, Department of Urology, Beijing Hospital, Beijing 100730, P.R. China
Published online on: September 24, 2019 https://doi.org/10.3892/or.2019.7333
Pages: 2788-2796

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Prostate cancer is closely associated with constitutive transactivation of the androgen receptor (AR) signaling pathway. After treatment with androgen‑deprivation therapy (ADT), the majority of patients develop castration‑resistant prostate cancer within months or years. In order to investigate potential novel therapeutic targets in addition to ADT, the present study examined the regulatory mechanisms of the AR signaling pathway. In the present study, LNCaP cells were metabolically‑labeled with Alk‑C16, a palmitate probe. In addition, cells were treated with R1881, an androgen, or DMSO. Subsequently, click‑chemistry‑based palmitoylome profiling was performed in LNCaP cells and palmitoylated proteins were compared between cells treated with androgen and untreated cells. Androgen treatment was revealed to significantly increase the palmitoylation level of α‑tubulin. In addition, the palmitoylation level of Ras‑related protein Rab‑7a (Rab7a) was enhanced by androgen treatment. Palmitoylation of α‑tubulin and Rab7a were essential for cell proliferation. Notably, in the supernatant of LNCaP cells, the palmitoylation level of α‑tubulin was also increased following androgen treatment. Palmitoylation of α‑tubulin may provide a new potential target for the treatment of prostate cancer. In addition, the high level of α‑tubulin palmitoylation in the supernatant may represent a biomarker for early‑stage prostate cancer.

View Figures

View References

1	Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
2	Lonergan PE and Tindall DJ: Androgen receptor signaling in prostate cancer development and progression. J Carcinog. 10:202011. View Article : Google Scholar : PubMed/NCBI
3	Klein EA, Ciezki J, Kupelian PA and Mahadevan A: Outcomes for intermediate risk prostate cancer: Are there advantages for surgery, external radiation, or brachytherapy? Urol Oncol. 27:67–71. 2009. View Article : Google Scholar : PubMed/NCBI
4	Loblaw DA, Virgo KS, Nam R, Somerfield MR, Ben-Josef E, Mendelson DS, Middleton R, Sharp SA, Smith TJ, Talcott J, et al: Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology Practice Guideline. J clin Oncol. 25:1596–1605. 2007. View Article : Google Scholar : PubMed/NCBI
5	Tilki D, Schaeffer EM and Evans CP: Understanding mechanisms of resistance in metastatic castration-resistant prostate cancer: The role of the androgen receptor. Eur Urol Focus. 2:499–505. 2016. View Article : Google Scholar : PubMed/NCBI
6	Aicart-Ramos C, Valero RA and Rodriguez-Crespo I: Protein palmitoylation and subcellular trafficking. Biochim Biophys Acta. 1808:2981–2994. 2011. View Article : Google Scholar : PubMed/NCBI
7	Thinon E and Hang HC: Chemical reporters for exploring protein acylation. Biochem Soc Trans. 43:253–261. 2015. View Article : Google Scholar : PubMed/NCBI
8	Mitchell DA, Vasudevan A, Linder ME and Deschenes RJ: Protein palmitoylation by a family of DHHC protein S-acyltransferases. J Lipid Res. 47:1118–1127. 2006. View Article : Google Scholar : PubMed/NCBI
9	Gao X and Hannoush RN: Single-cell imaging of Wnt palmitoylation by the acyltransferase porcupine. Nat Chem Biol. 10:61–68. 2014. View Article : Google Scholar : PubMed/NCBI
10	Pepinsky RB, Zeng C, Wen D, Rayhorn P, Baker DP, Williams KP, Bixler SA, Ambrose CM, Garber EA, Miatkowski K, et al: Identification of a palmitic acid-modified form of human sonic hedgehog. J Biol Chem. 273:14037–14045. 1998. View Article : Google Scholar : PubMed/NCBI
11	Hofmann K: A superfamily of membrane-bound O-acyltransferases with implications for wnt signaling. Trends Biochem Sci. 25:111–112. 2000. View Article : Google Scholar : PubMed/NCBI
12	Smotrys JE and Linder ME: Palmitoylation of intracellular signaling proteins: Regulation and function. Ann Rev Biochem. 73:559–587. 2004. View Article : Google Scholar : PubMed/NCBI
13	Resh MD: Targeting protein lipidation in disease. Trends Mol Med. 18:206–214. 2012. View Article : Google Scholar : PubMed/NCBI
14	Heakal Y, Woll MP, Fox T, Seaton K, Levenson R and Kester M: Neurotensin receptor-1 inducible palmitoylation is required for efficient receptor-mediated mitogenic-signaling within structured membrane microdomains. Cancer Biol Ther. 12:427–435. 2011. View Article : Google Scholar : PubMed/NCBI
15	Hannoush RN and Sun J: The chemical toolbox for monitoring protein fatty acylation and prenylation. Nat Chem Biol. 6:498–506. 2010. View Article : Google Scholar : PubMed/NCBI
16	Hernandez JL, Davda D, Majmudar JD, Won SJ, Prakash A, Choi AI and Martin BR: Correlated S-palmitoylation profiling of snail-induced epithelial to mesenchymal transition. Mol Biosyst. 12:1799–17808. 2016. View Article : Google Scholar : PubMed/NCBI
17	Greaves J, Munro KR, Davidson SC, Riviere M, Wojno J, Smith TK, Tomkinson NC and Chamberlain LH: Molecular basis of fatty acid selectivity in the zDHHC family of S-acyltransferases revealed by click chemistry. Proc Natl Acad Sci U S A. 114:E1365–E1374. 2017. View Article : Google Scholar : PubMed/NCBI
18	Li W, Li W, Zou L, Ji S, Li C, Liu K, Zhang G, Sun Q, Xiao F and Chen D: Membrane targeting of inhibitory Smads through palmitoylation controls TG-β/BMP signaling. Proc Natl Acad Sci USA. 114:13206–132011. 2017. View Article : Google Scholar : PubMed/NCBI
19	Hannoush RN and Arenas-Ramirez N: Imaging the lipidome: Omega-alkynyl fatty acids for detection and cellular visualization of lipid-modified proteins. ACS Chem Biol. 4:581–587. 2009. View Article : Google Scholar : PubMed/NCBI
20	Liu NQ, Braakman RB, Stingl C, Luider TM, Martens JW, Foekens JA and Umar A: Proteomics pipeline for biomarker discovery of laser capture microdissected breast cancer tissue. J Mammary Gland Biol Neoplasia. 17:155–164. 2012. View Article : Google Scholar : PubMed/NCBI
21	Shen LF, Chen YJ, Liu KM, Haddad ANS, Song IW, Roan HY, Chen LY, Yen JJY, Chen YJ, Wu JY and Chen YT: Role of S-palmitoylation by ZDHHC13 in mitochondrial function and metabolism in liver. Sci Rep. 7:21822017. View Article : Google Scholar : PubMed/NCBI
22	Caron JM: Posttranslational modification of tubulin by palmitoylation: I. In vivo and cell-free studies. Mol Biol Cell. 8:621–636. 1997. View Article : Google Scholar : PubMed/NCBI
23	Niu Y, Altuwaijri S, Lai KP, Wu CT, Ricke WA, Messing EM, Yao J, Yeh S and Chang C: Androgen receptor is a tumor suppressor and proliferator in prostate cancer. Proc Natl Acad Sci USA. 105:12182–12187. 2008. View Article : Google Scholar : PubMed/NCBI
24	Caron JM, Vega LR, Fleming J, Bishop R and Solomon F: Single site alpha-tubulin mutation affects astral microtubules and nuclear positioning during anaphase in Saccharomyces cerevisiae: Possible role for palmitoylation of alpha-tubulin. Mol Biol Cell. 12:2672–2687. 2001. View Article : Google Scholar : PubMed/NCBI
25	Caron JM and Herwood M: Vinblastine, a chemotherapeutic drug, inhibits palmitoylation of tubulin in human leukemic lymphocytes. Chemotherapy. 53:51–58. 2007. View Article : Google Scholar : PubMed/NCBI
26	Heuer TS, Ventura R, Mordec K, Lai J, Fridlib M, Buckley D and Kemble G: FASN inhibition and taxane treatment combine to enhance anti-tumor efficacy in diverse xenograft tumor models through disruption of tubulin palmitoylation and microtubule organization and FASN inhibition-mediated effects on oncogenic signaling and gene expression. EBioMedicine. 16:51–62. 2017. View Article : Google Scholar : PubMed/NCBI
27	Ng EL, Gan BQ, Ng F and Tang BL: Rab GTPases regulating receptor trafficking at the late endosome-lysosome membranes. Cell Biochem Function. 30:515–523. 2012. View Article : Google Scholar
28	Rink J, Ghigo E, Kalaidzidis Y and Zerial M: Rab conversion as a mechanism of progression from early to late endosomes. Cell. 122:735–749. 2005. View Article : Google Scholar : PubMed/NCBI
29	Bucci C, Thomsen P, Nicoziani P, McCarthy J and van Deurs B: Rab7: A key to lysosome biogenesis. Mol Biol Cell. 11:467–480. 2000. View Article : Google Scholar : PubMed/NCBI
30	Modica G, Skorobogata O, Sauvageau E, Vissa A, Yip CM, Kim PK, Wurtele H and Lefrancois S: Rab7 palmitoylation is required for efficient endosome-to-TGN trafficking. J Cell Sci. 130:2579–2590. 2017. View Article : Google Scholar : PubMed/NCBI
31	Guerra F and Bucci C: Multiple roles of the small GTPase Rab7. Cells. 5(pii): E342016. View Article : Google Scholar : PubMed/NCBI